Evidence map›Paper›PMID 34349232›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [

Chidera C Chukwueke, Christina N Nona, Matthew D McPhee, Esmaeil Mansouri, Dafna S Rubin-Kahana, Diana Martinez, Isabelle Boileau, Christian S Hendershot, Bernard Le Foll

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Chidera C ChukwuekeTranslational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. chidera.chukwueke@mail.utoronto.ca.
Christina N NonaMcGill University Faculty of Medicine, Montreal, QC, Canada.
Matthew D McPheeDepartment of Psychology, University of Toronto, Toronto, Canada.
Esmaeil MansouriAddiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-8906-1314
Dafna S Rubin-KahanaTranslational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Diana MartinezColumbia University Irving Medical Center, New York, NY, USA.
Isabelle BoileauAddiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-9901-1484
Christian S HendershotDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Bernard Le FollTranslational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-6406-4973
Centre for Addiction and Mental Health · CAColumbia University Irving Medical Center · USMcGill University · CAUniversity of North Carolina at Chapel Hill · USUniversity of Toronto · CA

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DAVID A. KAREKEN · 2003 to 2026
$45.5M
Exploring regulation and function of Dopamine D3 Receptors in Alcohol Use Disorders. A [11C]-(+)-PHNO PET studyR21AA023967 · NIAAA · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI LE FOLL, BERNARD · 2016 to 2017
$281k
NIAAA NIH HHS P60 AA007611NIAAA NIH HHS R21 AA023967
6 · The paper itself

Abstract

Preclinical studies support an important role of dopamine D3 receptors (DRD3s) in alcohol use disorder (AUD). In animals, voluntary alcohol consumption increases DRD3 expression, and pharmacological blockade of DRD3s attenuates alcohol self-administration and reinstatement of alcohol seeking. However, these findings have yet to be translated in humans. This study used positron emission tomography (PET) and [

Indexed as

AlcoholismAlcohol DrinkingBrainHumansOxazinesPositron-Emission TomographyProtein BindingReceptors, Dopamine D2Receptors, Dopamine D3DRD2 protein, humanDRD3 protein, humanOxazinesReceptors, Dopamine D2Receptors, Dopamine D3

Identifiers

PMID34349232
PMCPMC8336665
OpenAlexW3188593305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.